Alzheimer's disease is the most common cause of dementia that affects more than 6.5 million Americans, according to the Alzheimer's Association. To find effective treatments and slow the progression of this debilitating disease, ...
Sep 7, 2023
0
52
Led by the director of Virginia Commonwealth University's Stravitz-Sanyal Institute of Liver Disease and Metabolic Health, a consortium studying noninvasive tests for liver disease has demonstrated the effectiveness of five ...
Sep 7, 2023
0
17
Let's face it: We all want to move on from COVID-19. And with many of us vaccinated at some point, you might be wondering if it's time to let those pandemic worries go for good.
Sep 1, 2023
0
1
Two blood biomarkers could be predictive of cognitive deficits six and 12 months after a diagnosis of COVID-19, reports a new study published in Nature Medicine. These findings, based on data from more than 1,800 patients ...
Sep 1, 2023
0
47
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant ...
Aug 31, 2023
0
31
Almost one in five Danes experiences depression during their lives. A new study from Aarhus University now shows that the genetic risk of depression can be linked to an increased genetic risk of other psychiatric diagnoses. ...
Aug 29, 2023
0
91
Preeclampsia is a severe complication of pregnancy, affecting one in 40 pregnant women. Identifying high-risk patients is often difficult and complex because the exact cause of preeclampsia is still unknown.
Aug 29, 2023
0
14
The most impressive uses of artificial intelligence rely on good data—and lots of it. Chatbots, for example, learn to converse from millions of web pages full of text. Autonomous vehicles learn to drive from sensor data ...
Aug 29, 2023
0
47
For people with severe alcohol use disorder, a new gene therapy trial could lead to an effective treatment that would involve chemically rebalancing the area of the brain associated with addiction.
Aug 29, 2023
0
19
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, ...
Aug 23, 2023
0
44
